LifeScience Cell & Gene
FDA Approves iRegene's NouvNeu001, Marking Milestone in Parkinson's Disease Treatment
U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's...
June 25, 2024 | News
Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Advanced Cancer Profiling Services to Middle East and Africa
Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, h...
June 24, 2024 | News
Sarepta Therapeutics Secures FDA Approval for Expanded Use of ELEVIDYS in Duchenne Muscular Dystrophy Patients
Sarepta Therapeutics, the leader in precision genetic medicine for rare diseases, today announced U.S. Food and Drug Administration (FDA) approv...
June 21, 2024 | News
GC Cell and Bifarma Forge Strategic Partnership to Pioneer Cell Therapy Market in Indonesia
GC Cell, a fully integrated cell and gene therapy pioneer, is proud to announce the establishment of an MOU for strategic partnership with Bifarma, a ...
June 20, 2024 | News
Thermo Fisher Scientific Webinar on Next-Generation T Cell AOF Formulation Medium
Click here to register Thermo Fisher Scientific is excited to announce an upcoming webinar titled "Supporting Efficacy and Scaling with a Next-Gen...
June 19, 2024 | News
Gilead and Kite Oncology Announce Cost-Effectiveness of Yescarta® in Large B-Cell Lymphoma in Singapore
Gilead and Kite Oncology announced new data from analyses of Yescarta® (axicabtagene ciloleucel), demonstrating its cost-effectiveness and budget impac...
June 14, 2024 | News
Thermo Fisher Scientific Transforms Cell Therapy Production with New Automated CO2 Incubators
To support the future implementation of workflow automation in cell therapy production, Thermo Fisher Scientific introduces the Thermo Scientific™ He...
June 13, 2024 | News
Asgard Therapeutics Selects Exothera for Clinical Manufacturing of Cancer Gene Therapy AT-108
Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announced it s...
June 12, 2024 | News
Zymeworks Secures $8 Million Milestone Payment and Advances Cancer Treatment with FDA and NMPA Approvals
Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from Bei...
June 11, 2024 | News
Alphamab Oncology and ArriVent BioPharma Forge Strategic Collaboration to Develop Novel Antibody Drug Conjugates
Alphamab Oncology announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. , a wholly-owned subsidiary of the Company, entered into a research an...
June 06, 2024 | News
Annogen and Orchard Therapeutics Partner for Innovative Gene Therapy Research
Annogen, a company with expertise in bespoke promoter design and gene expression engineering, announced a research collaboration with Orchard Therape...
June 06, 2024 | News
HuidaGene Therapeutics and Synthego Corporation Forge Licensing Agreement for Advanced CRISPR Nuclease
HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corpo...
May 31, 2024 | News
Cytiva Launches Sefia: Advanced Platform to Transform CAR T Cell Therapy Manufacturing
Sefia cell therapy manufacturing platform comes out of Cytiva's extensive R&D expertise and in-depth understanding of CAR T manufacturing Automation...
May 30, 2024 | News
GCCL Introduces First ddPCR Device in South Korea for Enhanced Clinical Trial Sample Analysis
Introduced the first ddPCR device in Korea to provide high-quality clinical trial sample analysis services by increasing test accuracy Differentiate glo...
May 23, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
